resveratrol has been researched along with Epithelial Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Maitinuri, A; Muhanmode, Y; Shen, G; Wen, MK | 1 |
Gossner, G; He, G; Kueck, AS; Kuick, RD; Liu, JR; Opipari, AW; Tan, L; Wahl, H; Wang, W | 1 |
2 other study(ies) available for resveratrol and Epithelial Neoplasms
Article | Year |
---|---|
Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway.
Topics: Curcumin; Drug Resistance, Neoplasm; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Resveratrol | 2021 |
Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Carcinoma, Ovarian Epithelial; Cell Proliferation; Cell Survival; Cisplatin; Female; Glucose; Glycolysis; Humans; In Vitro Techniques; Mice; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays | 2016 |